Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ·Healthcare·Biotechnology
$533.38
+0.05%
Mkt Cap $12.50B
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (35 analysts)
$656.00
Range $542.00 – $964.00
Implied Upside
+23.0%
Consensus $656.00 vs current $533.38